Karyopharm Therapeutics (KPTI) Tax Provisions (2017 - 2025)
Karyopharm Therapeutics (KPTI) recorded Tax Provisions of -$67,000 in Q4 2025, compared with -$109,000 a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Tax Provisions (2017 - 2025) Analysis & Trends
For FY2025, Karyopharm Therapeutics reported Tax Provisions of $43,000, down 24.6% from FY2024.
- Annual Tax Provisions has declined for three straight years, with a five-year compound annual growth rate of -32.6% (FY2020 to FY2025).
- Across earlier years, Tax Provisions came in at $57,000 in FY2024 (-82.4%), $323,000 in FY2023 (-19.3%), $400,000 in FY2022 (+33.3%) and $300,000 in FY2021 (-2.9%).
- Quarterly Tax Provisions has ranged from -$109,000 in Q4 2024 to $149,000 in Q1 2021 over the past five years.
- On a year-over-year basis, Tax Provisions rose in three of the last six quarters, with growth averaging 8.2%.
- Peak year-over-year performance for Tax Provisions in the last five years was growth of 140.9% in Q3 2021, against a decline of 73.3% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $34,000 (Q3 2025), $40,000 (Q2 2025) and $36,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -1.01 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -291.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 393.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 242.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -407.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 292.00 Mn |
| 10 | Karyopharm Therapeutics | 35.30 Mn | -191.12 Mn | 32.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -67,000.00 |
| Sep 30, 2025 | 34,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | -109,000.00 |
| Sep 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Mar 31, 2024 | 71,000.00 |
| Dec 31, 2023 | 130,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 127,000.00 |
| Mar 31, 2023 | 54,000.00 |
| Dec 31, 2022 | 104,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Jun 30, 2022 | 121,000.00 |
| Mar 31, 2022 | 130,000.00 |
| Dec 31, 2021 | -89,000.00 |
| Sep 30, 2021 | 106,000.00 |
| Jun 30, 2021 | 134,000.00 |
| Mar 31, 2021 | 149,000.00 |
API Access
Karyopharm Therapeutics Tax Provisions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=tax-provisions&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "tax-provisions", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=tax-provisions&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();